Dolby Laboratories - DLB Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DLB shares.
View DLB analyst ratings or view top-rated stocks.

3 Wall Street analysts have issued 12 month price objectives for Dolby Laboratories' shares. Their DLB share price forecasts range from $85.00 to $116.00. On average, they predict the company's share price to reach $97.00 in the next year. This suggests a possible upside of 33.6% from the stock's current price.
View analysts price targets for DLB or view top-rated stocks among Wall Street analysts.

Dolby Laboratories' stock was trading at $95.22 on January 1st, 2022. Since then, DLB stock has decreased by 23.7% and is now trading at $72.61.
View the best growth stocks for 2022 here.

Dolby Laboratories saw a drop in short interest in October. As of October 15th, there was short interest totaling 764,300 shares, a drop of 5.6% from the September 30th total of 809,700 shares. Based on an average trading volume of 421,600 shares, the short-interest ratio is currently 1.8 days. Currently, 1.3% of the company's shares are sold short.
View Dolby Laboratories' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our DLB earnings forecast.

Dolby Laboratories, Inc. (NYSE:DLB) announced its earnings results on Tuesday, November, 16th. The electronics maker reported $0.58 EPS for the quarter, topping analysts' consensus estimates of $0.56 by $0.02. The electronics maker had revenue of $285.03 million for the quarter, compared to analyst estimates of $299.95 million. Dolby Laboratories had a trailing twelve-month return on equity of 9.19% and a net margin of 14.68%. The company's revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.28 EPS.

Dolby Laboratories announced a quarterly dividend on Thursday, November 17th. Shareholders of record on Wednesday, November 30th will be given a dividend of $0.27 per share on Thursday, December 8th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date is Tuesday, November 29th. This is a positive change from the stock's previous quarterly dividend of $0.25.
Read our dividend analysis for DLB.

Dolby Laboratories (NYSE:DLB) pays an annual dividend of $1.00 per share and currently has a dividend yield of 1.39%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DLB will have a dividend payout ratio of 35.21% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DLB.

Dolby Laboratories issued an update on its first quarter 2023 earnings guidance on Thursday, November, 17th. The company provided earnings per share (EPS) guidance of $0.76-$0.91 for the period, compared to the consensus EPS estimate of $1.10. The company issued revenue guidance of $300.00 million-$330.00 million, compared to the consensus revenue estimate of $364.08 million.

253 employees have rated Dolby Laboratories Chief Executive Officer Kevin J. Yeaman on Glassdoor.com. Kevin J. Yeaman has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital (IDCC), Energy Transfer (ET), Advanced Micro Devices (AMD), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), STAG Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories' stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (5.97%), Kayne Anderson Rudnick Investment Management LLC (4.02%), BlackRock Inc. (3.00%), Bank of New York Mellon Corp (1.72%), Disciplined Growth Investors Inc. MN (1.60%) and Mackenzie Financial Corp (1.44%). Insiders that own company stock include Avadis Tevanian, Emily Rollins, Giles Baker, John D Couling, Kenneth D Knight, Kevin J Yeaman, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay, Steven E Forshay and Todd Pendleton.
View institutional ownership trends.

Shares of DLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DLB stock can currently be purchased for approximately $72.61.

Dolby Laboratories (NYSE:DLB) has a market capitalization of $6.97 billion and generates $1.25 billion in revenue each year. The electronics maker earns $184.09 million in net income (profit) each year or $1.80 on an earnings per share basis.

The company employs 2,336 workers across the globe.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The official website for the company is www.dolby.com. The electronics maker can be reached via phone at (415) 558-0200, via email at investor@dolby.com, or via fax at 415-645-4000.